Skip to content

Clinical trials

Phase 2 Atrophy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrophy Phase: Phase 2 Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20101
20111
20142
20192
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen1
Assistance Publique - Hôpitaux de Paris1
Federal University of São Paulo1
Novartis Pharmaceuticals1
PepTonic Medical AB1
Scholar Rock, Inc.1
Shionogi1
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1
University of Kansas Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrophy9
Muscular Atrophy3
Demyelinating Diseases1
Frailty1
Hip Fractures1
Muscular Atrophy, Spinal1
Neuromuscular Diseases1
Neuromuscular Manifestations1
Pathological Conditions, Anatomical1
Spinal Muscular Atrophies of Childhood1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.